Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Covidien Gets FDA 510(k) Clearance For LigaSure Small Jaw, Open Sealer/divider

9/11/2012 7:14 AM ET

Covidien Ltd. (COV: Quote) said it secured 510(k) clearance from the U.S. Food and Drug Administration, or FDA, for the LigaSure curved, small jaw, open sealer/divider surgical instrument to be used in ear, nose and throat procedures.

According to the company, when working in confined surgical spaces, the proprietary LigaSure device addresses surgeons' needs by offering a low-temperature profile and minimal thermal spread to surrounding tissues. The LigaSure small jaw instrument provides an integrated cutting mechanism independent of sealing, leaving critical cutting decisions in the surgeon's hands.

In addition, LigaSure small jaw instrument's multifunctional design provides for blunt dissection and an enhanced experience for the surgeon, especially in confined surgical spaces. LigaSure technology, powered by the ForceTriad energy platform, gives surgeons a continuous output of energy, monitoring the tissue and making real-time adjustments 3,333 times/second to seal vessel walls.

Covidien noted that the new clearance, for the device's use in head and neck procedures, will allow for additional uses such as thyroidectomies, parotidectomies and additional open ENT procedures.

Register
To receive FREE breaking news email alerts for Covidien Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Starbucks Corp. said Thursday after the markets closed that its second quarter profit rose 9.4% from last year, helped by higher revenue. The company's quarterly earnings per share came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. The world's largest specialty coffee retailer also raised its full year earnings outlook. Software giant Microsoft Corp. said Thursday after the markets closed that its third quarter profit fell 6.6% from last year, when results were boosted by special upgrade offer revenues. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue. Apple Inc. said Wednesday after the markets closed that its second quarter profit rose 7% from last year, as sales surged and margins improved amid strong sales of its iPhones. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. At the same time, the company gave a slightly downbeat revenue forecast for the current quarter.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.